BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 9766814)

  • 1. Cell-surface antigen expression in early and term gestation fetal hematopoietic progenitor cells.
    Opie TM; Shields LE; Andrews RG
    Stem Cells; 1998; 16(5):343-8. PubMed ID: 9766814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candidate hematopoietic stem cells from fetal tissues, umbilical cord blood vs. adult bone marrow and mobilized peripheral blood.
    Huang S; Law P; Young D; Ho AD
    Exp Hematol; 1998 Nov; 26(12):1162-71. PubMed ID: 9808056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal development of human fetal hematopoiesis between eight and seventeen weeks' gestation.
    Pahal GS; Jauniaux E; Kinnon C; Thrasher AJ; Rodeck CH
    Am J Obstet Gynecol; 2000 Oct; 183(4):1029-34. PubMed ID: 11035358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly efficient gene transfer into preterm CD34 hematopoietic progenitor cells.
    Shields LE; Kiem HP; Andrews RG
    Am J Obstet Gynecol; 2000 Sep; 183(3):732-7. PubMed ID: 10992201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extensive amplification of single cells from CD34+ subpopulations in umbilical cord blood and identification of long-term culture-initiating cells present in two subsets.
    de Wynter EA; Nadali G; Coutinho LH; Testa NG
    Stem Cells; 1996 Sep; 14(5):566-76. PubMed ID: 8888497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional differences between subpopulations of mobilized peripheral blood-derived CD34+ cells expressing different levels of HLA-DR, CD33, CD38 and c-kit antigens.
    Sakabe H; Ohmizono Y; Tanimukai S; Kimura T; Mori KJ; Abe T; Sonoda Y
    Stem Cells; 1997; 15(1):73-81. PubMed ID: 9007225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic and functional characterization of committed and primitive myeloid and lymphoid hematopoietic precursors in human fetal liver.
    Roy V; Miller JS; Verfaillie CM
    Exp Hematol; 1997 May; 25(5):387-94. PubMed ID: 9168060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic analysis of early hematopoietic progenitors in cord blood and determination of their correlation with clonogenic progenitors: relevance to cord blood stem cell transplantation.
    Payne TA; Traycoff CM; Laver J; Xu F; Srour EF; Abboud MR
    Bone Marrow Transplant; 1995 Feb; 15(2):187-92. PubMed ID: 7539665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
    Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
    Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of the expression of CD38 and human leukocyte antigen-DR on CD34+ hematopoietic progenitor cells by interleukin-4 and interferon-gamma.
    Snoeck HW; Lardon F; Lenjou M; Nys G; Van Bockstaele DR; Peetermans ME
    Exp Hematol; 1993 Oct; 21(11):1480-6. PubMed ID: 7691636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD34++ CD38- and CD34+ CD38+ human hematopoietic progenitors from fetal liver, cord blood, and adult bone marrow respond differently to hematopoietic cytokines depending on the ontogenic source.
    Weekx SF; Van Bockstaele DR; Plum J; Moulijn A; Rodrigus I; Lardon F; De Smedt M; Nijs G; Lenjou M; Loquet P; Berneman ZN; Snoeck HW
    Exp Hematol; 1998 Oct; 26(11):1034-42. PubMed ID: 9766443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of CD34-positive cells and subpopulations in human umbilical cord blood and bone marrow.
    Kinniburgh D; Russell NH
    Bone Marrow Transplant; 1993 Nov; 12(5):489-94. PubMed ID: 7507766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High efficiency electroporation of human umbilical cord blood CD34+ hematopoietic precursor cells.
    Wu MH; Smith SL; Dolan ME
    Stem Cells; 2001; 19(6):492-9. PubMed ID: 11713340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of hemopoietic cell populations from human cord blood expressing c-kit.
    Reisbach G; Bartke I; Kempkes B; Kostka G; Ellwart J; Birner A; Thalmeier K; Mailhammer R; Bornkamm GW; Ullrich A
    Exp Hematol; 1993 Jan; 21(1):74-9. PubMed ID: 7678090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the coexpression of CD38, CD33 and HLA-DR antigens on CD34+ purified cells from human cord blood and bone marrow.
    De Bruyn C; Delforge A; Bron D; Bernier M; Massy M; Ley P; de Hemptinne D; Stryckmans P
    Stem Cells; 1995 May; 13(3):281-8. PubMed ID: 7613494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between IL-3 receptor expression and growth potential of human CD34+ hematopoietic cells from different tissues.
    Huang S; Chen Z; Yu JF; Young D; Bashey A; Ho AD; Law P
    Stem Cells; 1999; 17(5):265-72. PubMed ID: 10527461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of peripheral blood progenitor cells mobilized by nartograstim (N-terminal replaced granulocyte colony-stimulating factor) in normal volunteers.
    Maruyama K; Tsuji K; Tanaka R; Yamada K; Kodera Y; Nakahata T
    Bone Marrow Transplant; 1998 Aug; 22(4):313-20. PubMed ID: 9722064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human CD34(+) and CD34(+)CD38(-) hematopoietic progenitors in sickle cell disease differ phenotypically and functionally from normal and suggest distinct subpopulations that generate F cells.
    Luck L; Zeng L; Hiti AL; Weinberg KI; Malik P
    Exp Hematol; 2004 May; 32(5):483-93. PubMed ID: 15145217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel protocol that allows short-term stem cell expansion of both committed and pluripotent hematopoietic progenitor cells suitable for clinical use.
    Astori G; Malangone W; Adami V; Risso A; Dorotea L; Falasca E; Marini L; Spizzo R; Bigi L; Sala P; Tonutti E; Biffoni F; Rinaldi C; Del Frate G; Pittino M; Degrassi A
    Blood Cells Mol Dis; 2001; 27(4):715-24; discussion 725-7. PubMed ID: 11778655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro growth and quantification of early (CD33-/CD38-) myeloid progenitor cells: stem cell factor requirement and effects of previous chemotherapy.
    Ferrero D; Cherasco C; Ortolano B; Giaretta F; Bruno B
    Haematologica; 1999 May; 84(5):390-6. PubMed ID: 10329916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.